Long-term treatment with low doses of interferon ALFA-2B (rIFNa2b) in patients with chronic non-A, non-B (NANB) hepatitis: Data of a multicenter randomized prospectively controlled trial
- 31 December 1990
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
- Vol. 11, S46
- https://doi.org/10.1016/0168-8278(90)91520-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: